The health product developer has now raised more than $71m in debt and equity financing in total having received series C funding from backers including Mayo Clinic Ventures.

Tencent, Parkway Global and returning investor Lilly Asia Ventures all contributed to a series B round that boosted the cancer immunotherapy developer's total funding to $155m.

Lilly Asia Ventures and SBCVC both invested in the cancer diagnostics technology developer as part of a round that will fund research and development and strategic partnerships.

Guerbet, Caisse Centrale de Réassurances, L’Occitane and Sopra Steria were among the backers for the life sciences-focused venture firm's BioMedTech fund.

Bristol-Myers Squibb has exited Taris, which is developing a drug delivery system for bladder diseases, in a purchase by Johnson & Johnson.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Novartis, Merck & Co and Eli Lilly-backed Forma Therapeutics, which is working on treatments for rare haematologic diseases and cancers, has added $100m to its coffers.

Rev1 Catalyst Fund II will fund startups generated through research by Nationwide Children’s Hospital, which has also backed the vehicle.

Cogitativo, developer of a data analysis platform for healthcare, has closed an $18.5m round led by Wells Fargo Strategic Capital.

Scale Venture Partners has led a $50m funding round for Wanxiang-backed medical data repository provider OM1 that will support product development, sales and marketing.